ペンシルベニアにおける卵巣上皮性癌の臨床試験
ペンシルベニア内の拠点で、卵巣上皮性癌に関する10件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- St. Lukes University Hospital /ID# 274362, Bethlehem
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05867251ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
- Research Site, York
被験者募集中第3相
18歳以上 · 女性 · 2026/07/21更新 · NCT07218809Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- St. Lukes University Health Network, Bethlehem
- Ann B Barshinger Cancer Institute, Lancaster
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007CT-95 in Advanced Cancers Associated With Mesothelin Expression
- University of Pennsylvania, Philadelphia
- Context Investigational Site, Philadelphia
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06756035A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/27更新 · NCT06395519A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 女性 · 2026/02/03更新 · NCT06469281CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- SCRI - Alliance Cancer Specialists, PC, Doylestown
- University of Pennsylvania, Philadelphia
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- UPMC Hillman Cancer Center, Pittsburgh
被験者募集中第1相
18歳以上 · 全性別 · 2025/08/15更新 · NCT04429542ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。